La Jolla, CA, United States of America

Hongbo Pang


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hongbo Pang

Introduction

Hongbo Pang is a notable inventor based in La Jolla, California. He has made significant contributions to the field of medical research, particularly in targeting activated macrophages for therapeutic purposes. His work focuses on developing innovative solutions that can enhance the effectiveness of treatments for various diseases.

Latest Patents

Hongbo Pang holds a patent for a "Tumor associated monocyte/macrophage binding peptide and methods of use thereof." This patent discloses compositions and methods that are useful for targeting molecules to activated macrophages, such as tumor-associated macrophages. The compositions are based on peptide sequences, like AMT peptides, that home to activated macrophages. This innovative approach is beneficial for delivering therapeutic and detectable agents to cells and tissues where immune system effects or inflammation are occurring.

Career Highlights

Pang is affiliated with the Sanford Burnham Prebys Medical Discovery Institute, where he conducts research aimed at advancing medical science. His work has the potential to impact the treatment of various conditions by improving the targeting of therapies to specific cells involved in disease processes.

Collaborations

Hongbo Pang collaborates with esteemed colleagues in his field, including Erkki I Ruoslahti. These partnerships enhance the research efforts and contribute to the development of innovative medical solutions.

Conclusion

Hongbo Pang's contributions to medical research through his innovative patent and collaborations highlight the importance of targeted therapies in modern medicine. His work continues to pave the way for advancements in the treatment of diseases involving activated macrophages.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…